These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 3497227

  • 1. Dominantly inherited Alzheimer's disease: cerebral glucose metabolism.
    Polinsky RJ, Noble H, Di Chiro G, Nee LE, Feldman RG, Brown RT.
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):752-7. PubMed ID: 3497227
    [Abstract] [Full Text] [Related]

  • 2. Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
    Fukuyama H, Harada K, Yamauchi H, Miyoshi T, Yamaguchi S, Kimura J, Kameyama M, Senda M, Yonekura Y, Konishi J.
    J Neurol Sci; 1991 Dec; 106(2):128-34. PubMed ID: 1802960
    [Abstract] [Full Text] [Related]

  • 3. Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer's disease.
    Cutler NR, Haxby JV, Duara R, Grady CL, Moore AM, Parisi JE, White J, Heston L, Margolin RM, Rapoport SI.
    Neurology; 1985 Nov; 35(11):1556-61. PubMed ID: 3877253
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Positron emission tomography and familial Alzheimer's disease: a pilot study.
    Guze BH, Hoffman JM, Mazziotta JC, Baxter LR, Phelps ME.
    J Am Geriatr Soc; 1992 Feb; 40(2):120-3. PubMed ID: 1740595
    [Abstract] [Full Text] [Related]

  • 6. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P, Dani A, Furey ML, Alexander GE, Freo U, Grady CL, Mentis MJ, Mangot D, Simon EW, Horwitz B, Haxby JV, Schapiro MB.
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [Abstract] [Full Text] [Related]

  • 7. Altered cerebral energy metabolism in Alzheimer's disease: a PET study.
    Fukuyama H, Ogawa M, Yamauchi H, Yamaguchi S, Kimura J, Yonekura Y, Konishi J.
    J Nucl Med; 1994 Jan; 35(1):1-6. PubMed ID: 8271029
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alzheimer's disease: focal cortical changes shown by positron emission tomography.
    Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, Di Chiro G.
    Neurology; 1983 Aug; 33(8):961-5. PubMed ID: 6603596
    [Abstract] [Full Text] [Related]

  • 10. [A longitudinal study of CMRGlu in dementia of Alzheimer type].
    Kuwabara Y, Ichiya Y, Ichimiya A, Sasaki M, Akashi Y, Yoshida T, Fukumura T, Masuda K.
    Kaku Igaku; 1994 Oct; 31(10):1255-60. PubMed ID: 7807730
    [Abstract] [Full Text] [Related]

  • 11. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P, Furey ML, Graff-Radford N, Freo U, Alexander GE, Grady CL, Dani A, Mentis MJ, Schapiro MB.
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [Abstract] [Full Text] [Related]

  • 12. The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography.
    Foster NL, VanDerSpek AF, Aldrich MS, Berent S, Hichwa RH, Sackellares JC, Gilman S, Agranoff BW.
    J Cereb Blood Flow Metab; 1987 Aug; 7(4):415-20. PubMed ID: 3497161
    [Abstract] [Full Text] [Related]

  • 13. Physostigmine in Alzheimer's disease: effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography.
    Tune L, Brandt J, Frost JJ, Harris G, Mayberg H, Steele C, Burns A, Sapp J, Folstein MF, Wagner HN.
    Acta Psychiatr Scand Suppl; 1991 Aug; 366():61-5. PubMed ID: 1897377
    [Abstract] [Full Text] [Related]

  • 14. Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndrome.
    Cutler NR.
    Prog Neuropsychopharmacol Biol Psychiatry; 1986 Aug; 10(3-5):309-21. PubMed ID: 2948218
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.
    Alexander GE, Furey ML, Grady CL, Pietrini P, Brady DR, Mentis MJ, Schapiro MB.
    Am J Psychiatry; 1997 Feb; 154(2):165-72. PubMed ID: 9016263
    [Abstract] [Full Text] [Related]

  • 17. The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.
    Sultzer DL, Mahler ME, Mandelkern MA, Cummings JL, Van Gorp WG, Hinkin CH, Berisford MA.
    J Neuropsychiatry Clin Neurosci; 1995 Feb; 7(4):476-84. PubMed ID: 8555751
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
    Farkas T, Ferris SH, Wolf AP, De Leon MJ, Christman DR, Reisberg B, Alavi A, Fowler JS, George AE, Reivich M.
    Am J Psychiatry; 1982 Mar; 139(3):352-3. PubMed ID: 6977276
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.